Second, I13 efficiently depletes BCR-ABL, which blocks its function as a scaffold protein that modulates the chronic myeloid leukemia signaling pathway mediating cell differentiation. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.